Interim Results of a Prospective Phase 2 Trial of Pelvic IMRT, Cesium-131 Brachytherapy Boost, Adjuvant Docetaxel Chemotherapy, and Long-term Androgen Ablation for Patients With High-Risk Prostate Cancer

✍ Scribed by Kwok, Y.; Ferris, M.; Moshe, M.; Kataria, R.; Nickerson, C.

• Book ID: 122562000
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 45 KB
• Volume: 87
• Category: Article
• ISSN: 0360-3016
• DOI: 10.1016/j.ijrobp.2013.06.328